Bayer AG
F:BAYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bayer AG
F:BAYA
|
DE |
|
Boston Properties Inc
NYSE:BXP
|
US |
|
T
|
Terex Corp
XMUN:TXG
|
US |
|
F
|
FedEx Corp
XETRA:FDX
|
US |
|
Great Southern Bancorp Inc
NASDAQ:GSBC
|
US |
|
A
|
ANSYS Inc
SWB:AKX
|
US |
|
Lucid Group Inc
F:CH2
|
US |
|
A
|
Accuray Inc
XBER:XEJ
|
US |
|
S
|
Star Entertainment Group Ltd
F:EE9
|
AU |
|
D
|
Deutsche EuroShop AG
XMUN:DEQ
|
DE |
|
Azienda Bresciana Petroli Nocivelli SpA
F:9UZ
|
IT |
|
W
|
Woodside Energy Group Ltd
F:WOP0
|
AU |
|
P
|
PepsiCo Inc
SIX:PEP
|
US |
|
A
|
AXA SA
XBER:AXA
|
FR |
|
Continental AG
F:CONA
|
DE |
|
H
|
Huron Consulting Group Inc
F:HUR
|
US |
|
LVMH Moet Hennessy Louis Vuitton SE
XETRA:MOH
|
FR |
|
P
|
PagerDuty Inc
F:2TY
|
US |
|
Berkshire Hathaway Inc
BMV:BRKB
|
US |
|
S
|
Sempra Energy
F:SE4
|
US |
|
C
|
China Petroleum & Chemical Corp
F:CHUA
|
CN |
|
Moody's Corp
BMV:MCO
|
US |
|
M&T Bank Corp
F:MTZ
|
US |
|
VICI Properties Inc
NYSE:VICI
|
US |
Bankruptcy Probability
Bayer AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bayer AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Bayer AG
XETRA:BAYN
|
36.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
88.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Zoetis Inc
NYSE:ZTS
|
37.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
5.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
535.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bayer AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bayer AG has total debt of 31.8B EUR. This includes both short-term (0 EUR) and long-term (31.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
